Share-based Payment Arrangement, Expense in USD of BriaCell Therapeutics Corp. from Q3 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BriaCell Therapeutics Corp. quarterly Share-based Payment Arrangement, Expense history and change rate from Q3 2022 to Q1 2024.
  • BriaCell Therapeutics Corp. Share-based Payment Arrangement, Expense for the quarter ending 30 Apr 2024 was $392K, a 39.5% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $392K +$111K +39.5% 01 Feb 2024 30 Apr 2024 10-Q 14 Jun 2024
Q4 2023 $500K +$233K +87.4% 01 Nov 2023 31 Jan 2024 10-Q 18 Mar 2024
Q3 2023 $534K -$578K -52% 01 Aug 2023 31 Oct 2023 10-Q 14 Dec 2023
Q1 2023 $281K 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024
Q4 2022 $267K 01 Nov 2022 31 Jan 2023 10-Q 18 Mar 2024
Q3 2022 $1.11M 01 Aug 2022 31 Oct 2022 10-Q 14 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.